EC Number | Application | Comment | Organism |
---|---|---|---|
1.2.1.105 | medicine | susceptibility of KGDHC to inactivation in kidney cells exposed to cisplatin metabolites my be due to the proximity of mitochondrial aspartate aminotransferase to KGDHC in mitochondria, mitochondrial aspartate aminotransferase may catalyze a beta-lyase reaction with the cisplatin-cysteine S-conjugate, converting cisplatin to a toxicant | Sus scrofa |
EC Number | Cloned (Comment) | Organism |
---|---|---|
4.4.1.13 | - |
Rattus norvegicus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.2.1.105 | cisplatin | treatment with 0.05 or 0.1 mM for 3 h, followed by removal of cisplatin from the medium for 24 h, results in a pronounced loss of activity, both in mitochondrial aspartate aminotransferase-transfected cells and control cells, exposure to 0.1 mM results in a significantly greater loss of activity in mitochondrial aspartate aminotransferase-transfected cells than in control cells | Sus scrofa | |
4.4.1.13 | aminooxyacetic acid | - |
Mus musculus | |
4.4.1.13 | aminooxyacetic acid | - |
Rattus norvegicus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
1.2.1.105 | mitochondrion | - |
Sus scrofa | 5739 | - |
4.4.1.13 | cytosol | - |
Mus musculus | 5829 | - |
4.4.1.13 | microsome | - |
Mus musculus | - |
- |
4.4.1.13 | mitochondrion | - |
Mus musculus | 5739 | - |
4.4.1.13 | mitochondrion | - |
Rattus norvegicus | 5739 | - |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.2.1.105 | Sus scrofa | - |
- |
- |
4.4.1.13 | Mus musculus | - |
- |
- |
4.4.1.13 | Rattus norvegicus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.2.1.105 | kidney | - |
Sus scrofa | - |
1.2.1.105 | LLC-PK1 cell | - |
Sus scrofa | - |
4.4.1.13 | kidney | - |
Mus musculus | - |
4.4.1.13 | liver | - |
Rattus norvegicus | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
4.4.1.13 | 25 | - |
- |
Rattus norvegicus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
4.4.1.13 | (H2N)2Pt(Cl)SCH2CH(NH3+)CO2- + H2O | - |
Mus musculus | CH3C(O)CO2- + NH4+ + (NH2)2Pt(Cl)SH | - |
? | |
4.4.1.13 | (H2N)2Pt(Cl)SCH2CH(NH3+)CO2- + H2O | - |
Rattus norvegicus | CH3C(O)CO2- + NH4+ + (NH2)2Pt(Cl)SH | - |
? | |
4.4.1.13 | S-(1,1,2,2-tetrafluoroethyl)-L-cysteine | - |
Mus musculus | ? | - |
? | |
4.4.1.13 | S-(1,2-dichlorovinyl)-L-cysteine | - |
Mus musculus | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.2.1.105 | alpha-ketoglutarate dehydrogenase complex | - |
Sus scrofa |
1.2.1.105 | KGDHC | - |
Sus scrofa |
4.4.1.13 | cysteine S-conjugate beta-lyase | - |
Mus musculus |
4.4.1.13 | cysteine S-conjugate beta-lyase | - |
Rattus norvegicus |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
4.4.1.13 | pyridoxal 5'-phosphate | - |
Mus musculus | |
4.4.1.13 | pyridoxal 5'-phosphate | - |
Rattus norvegicus |